Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This clinical pharmacology want to investigate the systemic availability of BDP/B17MP (active metabolite of BDP) and formoterol after single oral inhalation of CHF 1535 100/6 pMDI with and without spacer device (AeroChamber Plus™) and in comparison to a free combination of BDP pMDI plus formoterol pMDI licensed products; this will be additionally compared to the systemic exposure in adults without the spacer device.
Epistemonikos ID: 3bfd614b4661e50fef36d5566e11aeee56017d77
First added on: May 11, 2024